India, March 8 -- Alumis Inc. (ALMS) announced positive 52-week data from the open-label extension (OLE) of its Phase 2 STRIDE clinical trial evaluating ESK-001 in patients with moderate-to-severe pla... Read More
India, March 8 -- Johnson & Johnson (JNJ) announced new icotrokinra (JNJ-2113) data from its Phase 3 clinical program and the start of the first-ever head-to-head study in plaque psoriasis (PsO) seeki... Read More
India, March 8 -- Eli Lilly and Co. (LLY) and Incyte's (INCY) late-breaking results from Phase 3 BRAVE-AA-PEDS study found adolescent patients (ages 12 to under 18) with severe alopecia areata treated... Read More
India, March 8 -- Regeneron Pharmaceuticals Inc. (REGN) and Sanofi presented positive results from the pivotal ADEPT Phase 2/3 trial evaluating the investigational use of Dupixent (dupilumab) in adult... Read More
India, March 8 -- Amgen (AMGN) and Kyowa Kirin Co., Ltd. announced new results from the ongoing ROCKET Phase 3 clinical trial program evaluating rocatinlimab, an investigational T-cell rebalancing the... Read More
India, March 8 -- Q32 Bio Inc. (QTTB) announced additional results from Part A of its SIGNAL-AA Phase 2a clinical trial of bempikibart in patients with alopecia areata (AA) at the 2025 American Academ... Read More
India, March 7 -- The Canadian dollar declined against its major counterparts in the New York session on Friday, as disappointing jobs data raised expectations that the Bank of Canada will cut interes... Read More
India, March 7 -- Modine Manufacturing Co. (MOD), a global company in thermal management technology, Friday announced a share repurchase program authorizing the company to buy back up to $100 million ... Read More
India, March 7 -- Shares of GEN Restaurant Group, Inc. (GENK) surged nearly 40% on Friday morning after reporting fourth-quarter results, with revenues increasing over 20%. GENK is currently trading ... Read More
India, March 7 -- Porsche Automobil Holding SE expects group loss after tax for the fiscal year 2024 to be approximately 20.0 billion euros, primarily hurt by non-cash impairment losses identified thr... Read More